How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,319 results for

Atrioventricular Block

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Atrioventricular block

Atrioventricular block Atrioventricular block - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Atrioventricular block Last reviewed: February 2019 Last updated: January 2018 Summary AV block can be described by degree (based on ECG appearance) or by anatomical level of block. The degree of AV block or anatomical level of block does not necessarily correlate with the severity of subsequent symptoms. The goals (...) of therapy are to treat symptoms and to prevent syncope and sudden cardiac death due to very slow or absent ventricular rates. Patients with advanced AV block (usually type II second-degree, third-degree, or infranodal AV block) of irreversible cause should undergo permanent pacemaker placement. Definition Atrioventricular (AV) block is a cardiac electrical disorder defined as impaired (delayed or absent) conduction from the atria to the ventricles. The severity of the conduction abnormality is described

2018 BMJ Best Practice

2. Second-degree Atrioventricular Block: Conceptions and Misconceptions Full Text available with Trip Pro

Second-degree Atrioventricular Block: Conceptions and Misconceptions 29977560 2018 11 14 2050-3369 7 2 2018 Jun Arrhythmia & electrophysiology review Arrhythm Electrophysiol Rev Second-degree Atrioventricular Block: Conceptions and Misconceptions. 77-78 10.15420/aer.2018.7.2.EO1 Katritsis Demosthenes G DG Hygeia Hospital Athens, Greece. eng Journal Article Review England Arrhythm Electrophysiol Rev 101637930 2050-3369 Atrioventricular block His-Purkinje QRS complex type I block type II block

2018 Arrhythmia & electrophysiology review

3. Single Versus Dual Lead Atrioventricular Sequential Pacing for Acquired Atrioventricular Block During Transcatheter Aortic Valve Implantation Procedures. (Abstract)

Single Versus Dual Lead Atrioventricular Sequential Pacing for Acquired Atrioventricular Block During Transcatheter Aortic Valve Implantation Procedures. Atrioventricular block (AVB) after transcatheter aortic valve implantation (TAVI) is common. Pacing platforms that preserve atrioventricular (AV) synchrony may be beneficial in these patients. Single lead AV sequential pacemakers (VDD) allow AV synchrony and, by virtue of implanting a single lead, can be advantageous when compared

2018 American Journal of Cardiology

4. Dual chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block

Dual chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block Dual-chamber pacemak Dual-chamber pacemakers for ers for symptomatic br symptomatic brady adycardia due to sick cardia due to sick sinus syndrome without atrio sinus syndrome without atriov ventricular entricular block block T echnology appraisal guidance Published: 26 November 2014 nice.org.uk/guidance/ta324 © NICE 2018. All rights reserved. Subject to Notice of rights (https (...) to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block (TA324) © NICE 2018. All rights

2014 National Institute for Health and Clinical Excellence - Technology Appraisals

5. Use of biventricular pacing in atrioventricular heart block

Use of biventricular pacing in atrioventricular heart block Use of biventricular pacing in atrioventricular heart block Use of biventricular pacing in atrioventricular heart block Saab L, Suarthana E, Almeida N, Dendukuri N. Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Saab L, Suarthana E, Almeida N, Dendukuri N.. Use of biventricular (...) pacing in atrioventricular heart block. Montreal: Technology Assessment Unit of the McGill University Health Centre (MUHC). 2016 Authors' objectives The objective of this report is to systematically review the evidence for the use of BVP, as either a de novo implant or as an upgrade, in the management of AV block with normal left ventricular systolic function at the MUHC. Authors' conclusions The available evidence regarding the use of BVP in AV block patients is weak in terms of the number

2016 Health Technology Assessment (HTA) Database.

6. Utility of electrophysiologic studies for prediction of complete atrioventricular block in patients with syncope and bifascicular conduction block: A systematic review and meta-analysis

Utility of electrophysiologic studies for prediction of complete atrioventricular block in patients with syncope and bifascicular conduction block: A systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

7. Use of Biventricular Pacing in Atrioventricular Heart Block

Use of Biventricular Pacing in Atrioventricular Heart Block Report available from http://www.mcgill.ca/tau Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of Biventricular Pacing in Atrioventricular Heart Block Report number: 78 DATE: March 8, 2016 Report available from http://www.mcgill.ca/tau Report prepared for the Technology Assessment Unit (TAU)of the McGill University Health Centre (MUHC) by Lama Saab, Eva Suarthana, Nisha Almeida and Nandini Dendukuri (...) Approved by the Committee of the TAU on 29 January, 2016 TAU Committee Andre Bonnici, James Brophy, Christos Calaritis, Nandini Dendukuri, Liane Feldman, Patricia Lefebvre, Brenda MacGibbon-Taylor, Teresa Mack, Nancy Mayo, Maurice McGregor, Patty O’Connor Suggested citation Saab L., Suarthana E., Almeida N., Dendukuri N. Use of Biventricular Pacing in Atrioventricular Heart Block Montreal. (Canada): Technology Assessment Unit (TAU) of the McGill University Health Centre (MUHC); 8 March 2016. Report

2016 McGill TAU reports

8. Slow pathway modification for treatment of pseudo-pacemaker syndrome due to first-degree atrioventricular block with dual atrioventricular nodal physiology Full Text available with Trip Pro

Slow pathway modification for treatment of pseudo-pacemaker syndrome due to first-degree atrioventricular block with dual atrioventricular nodal physiology 29707483 2019 02 26 2214-0271 4 3 2018 Mar HeartRhythm case reports HeartRhythm Case Rep Slow pathway modification for treatment of pseudo-pacemaker syndrome due to first-degree atrioventricular block with dual atrioventricular nodal physiology. 98-101 10.1016/j.hrcr.2017.10.003 Lader Joshua M JM New York University School of Medicine, New (...) Pacemaker syndrome Pseudo-pacemaker syndrome Slow pathway Symptomatic first-degree AV block 2018 5 1 6 0 2018 5 1 6 0 2018 5 1 6 1 epublish 29707483 10.1016/j.hrcr.2017.10.003 S2214-0271(17)30171-9 PMC5919070 Pacing Clin Electrophysiol. 1996 May;19(5):747-51 8734740 Europace. 2010 Apr;12(4):594-6 19946114 Arch Cardiovasc Dis. 2013 Dec;106(12 ):690-3 23791585 JAMA. 2009 Jun 24;301(24):2571-7 19549974 J Cardiovasc Electrophysiol. 1993 Apr;4(2):178-82 8269289 J Cardiovasc Electrophysiol. 1994 Aug;5(8):645

2017 HeartRhythm Case Reports

9. Permanent left bundle branch area pacing for atrioventricular block: feasibility, safety and acute effect. Full Text available with Trip Pro

Permanent left bundle branch area pacing for atrioventricular block: feasibility, safety and acute effect. Left bundle branch area pacing (LBBAP), a new pacing approach, lacks adequate evaluation.To assess the feasibility, safety, and acute effect of permanent LBBAP in patients with atrioventricular block (AVB).A total of 33 AVB patients with indications for ventricular pacing were recruited. Electrocardiograms, pacing parameters, echocardiographic measurements and complications associated (...) with LBBAP were evaluated perioperatively and at 3-month follow-up. Successful LBBAP was defined as a paced QRS morphology of right bundle branch block pattern in lead V1 and QRS duration (QRSd) less than 130 ms.LBBAP was successfully performed in 90.9% (30/33) of patients (mean age: 55.1±18.5 years; 66.7% male). The mean capture threshold was similar during the procedure (0.76±0.26 V at 0.4 ms) and at the 3-month follow-up (0.64±0.20 V at 0.4 ms). The paced QRSd was 112.8 ± 10.9 ms during the procedure

2019 Heart Rhythm

10. Ambulatory Rhythm Monitoring to Detect Late High-Grade Atrioventricular Block Following Transcatheter Aortic Valve Replacement. (Abstract)

Ambulatory Rhythm Monitoring to Detect Late High-Grade Atrioventricular Block Following Transcatheter Aortic Valve Replacement. High-grade atrioventricular block (H-AVB) is a well-described in-hospital complication of transcatheter aortic valve replacement (TAVR). Delayed high-grade atrioventricular block (DH-AVB) has not been systematically studied among outpatients post-TAVR, using latest-generation TAVR technology and in the early post-TAVR discharge era.The purpose of this study (...) TAVR patients without a prior pacing device, 18 (12%) developed H-AVB necessitating permanent pacemaker <2 days post-TAVR, 1 died pre-discharge, and 13 declined AEM; 118 had 30-day AEM data. DH-AVB occurred in 12 (10% of AEM patients, 8% of total cohort) a median of 6 days (range 3 to 24 days) post-TAVR. DH-AVB versus non-AVB patients were more likely to have hypertension and right bundle branch block (RBBB). Sensitivity and specificity of RBBB in predicting DH-AVB was 27% and 94%, respectively.DH

2019 Journal of the American College of Cardiology

11. Complete atrioventricular block caused by pulmonary embolism: A case report and review of literature. (Abstract)

Complete atrioventricular block caused by pulmonary embolism: A case report and review of literature. Acute electrocardiogram abnormalities are common in patients afflicted with pulmonary embolism (PE). Rarely, a patient with acute pulmonary embolism and electrocardiogram changes may have an underlying conduction abnormality that complicates their course.We describe a patient with known history of left bundle branch block who presented with acute PE and developed a right bundle branch block (...) , which devolved into complete third degree heart block without ventricular escape rhythm and led to concomitant hemodynamic compromise.Given the rarity of this clinical scenario, we call for clinicians to be aware of PE-associated conduction pathology as well as the possibility that malignant cardiac conduction blocks may occur in the setting of PE particularly if the patient is known to have underlying conduction system disease. We emphasize the importance of continuous telemetry monitoring

2019 Heart & Lung

12. Prevalence of first-degree atrioventricular block and the associated risk factors: a cross-sectional study in rural Northeast China. Full Text available with Trip Pro

Prevalence of first-degree atrioventricular block and the associated risk factors: a cross-sectional study in rural Northeast China. First-degree atrioventricular block (AVB) has traditionally been regarded as a benign condition but recent studies have challenged this conception. Prevalence of 1-2% have been reported in developed countries in Asia. However, no epidemiologic studies have established the prevalence of first-degree AVB in developing countries. The aim of the study

2019 BMC Cardiovascular Disorders

13. Atrioventricular block after congenital heart surgery: Analysis from the Pediatric Cardiac Critical Care Consortium. (Abstract)

Atrioventricular block after congenital heart surgery: Analysis from the Pediatric Cardiac Critical Care Consortium. Our primary aims were to describe the contemporary epidemiology of postoperative high-grade atrioventricular block (AVB), the timing of recovery and permanent pacemaker (PPM) placement, and to determine predictors for development of and recovery from AVB.Patients who underwent congenital heart surgery from August 2014 to June 2017 were analyzed for AVB using the Pediatric Cardiac

2019 Journal of Thoracic and Cardiovascular Surgery

14. Acute myocarditis complicated with permanent complete atrioventricular block caused by Escherichia coli bacteremia: A rare case report. Full Text available with Trip Pro

Acute myocarditis complicated with permanent complete atrioventricular block caused by Escherichia coli bacteremia: A rare case report. Acute myocarditis complicated with complete atrioventricular block (CAVB) is rare in clinical scenario. We report an uncommon case of myocarditis complicated with permanent CAVB caused by Escherichia coli (E coli) bacteremia.A 77-year-old woman presented at the emergency department with chest pain, dizziness, nausea, and cold sweats of 1-day duration. She had

2019 Medicine

15. Very late-onset complete atrioventricular block following deployment of Amplatzer membranous ventricular septal defect occluder. Full Text available with Trip Pro

Very late-onset complete atrioventricular block following deployment of Amplatzer membranous ventricular septal defect occluder. Although implantation of Amplatzer membranous ventricular septal defect occluder (AVSDO) is an alternation to surgical treatment, the interventional therapy is disapproved by FDA due to high incidence of complete atrioventricular block (cAVB) post closure during early and middle term follow-up. However, long-term outcomes of the accumulating numbers of patients who (...) had received AVSDO in the past decades, still remain an issue of concern and late occurrence of potentially catastrophic heart block long after hospital discharge is especially worrying, but rarely documented. We firstly reported a pediatric case with very late-onset cAVB occurring over ten years following transcatheter closure of PmVSD using AVSDO.A 5-year old female received transcatheter closure of PmVSD sized 10-mm on left ventricular angiography with a 14-mm AVSDO owning to a history

2019 Medicine

16. Masquerading bundle branch block as a presenting manifestation of complete atrioventricular block that caused syncope Full Text available with Trip Pro

Masquerading bundle branch block as a presenting manifestation of complete atrioventricular block that caused syncope A 59-year-old male patient was admitted with the main complaints of stuffiness and shortness of breath. An ECG from precordial leads on admission showed masquerading bundle branch block. Syncope frequently occurred after admission. During syncope episodes, ECG telemetry showed that the syncope was caused by intermittent complete atrioventricular block, with the longest RR (...) interval lasting for 4.36 s. At the gap of syncope, ECG showed complete right bundle branch block accompanied by alternation of left anterior fascicular block and left posterior fascicular block. The patient was implanted with a dual-chamber permanent pacemaker. Follow-up of 9 months showed no reoccurrence of syncope.

2017 The Journal of international medical research

17. Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer. Full Text available with Trip Pro

Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer. Synthetic cannabinoid intoxication has become difficult to diagnose and manage in the United States, in part due to varying clinical effects within this heterogeneous group of compounds.A 38-year-old man was admitted with altered mental status and bradycardia. He demonstrated progressive encephalopathy, seizure activity, second-degree atrioventricular block type I, respiratory failure, hypotension

2018 Journal of Emergency Medicine

18. Frequency and Significance of High-Degree Atrioventricular Block and Sinoatrial Node Dysfunction in Patients With Non-ST-Elevation Myocardial Infarction. (Abstract)

Frequency and Significance of High-Degree Atrioventricular Block and Sinoatrial Node Dysfunction in Patients With Non-ST-Elevation Myocardial Infarction. Characteristics of conduction disorders after ST-elevation myocardial infarction (STEMI) have been well described. In contrast, limited data are available on the incidence, treatment trends, and prognostic impact of conduction disorders after non-ST-elevation myocardial infarction (NSTEMI). Using the National Inpatient Sample database, we (...) compared the characteristics and outcomes of conduction disorders in patients with a primary diagnosis of STEMI versus NSTEMI between 2010 and 2014. Conduction disorders were classified into‬ high-degree AV block (HDAVB), consisting of complete AV block or Mobitz type II second-degree AV block, and sinoatrial node dysfunction (SND). We identified 135,468 STEMI patients and 281,928 NSTEMI patients. In contrast to the STEMI cohort where HDAVB was more common than SND (2.4% vs 0.5%), SND was observed more

2018 American Journal of Cardiology

19. High-grade atrioventricular block Full Text available with Trip Pro

High-grade atrioventricular block Atrioventricular (AV) block is an AV conduction disorder that can manifest in various settings, with varying symptomaticity and severity. The electrocardiogram is a key diagnostic tool for management, and careful interpretation is necessary to institute the correct management. We described two cases of patients with bradycardia due to AV blocks and discussed the electrocardiogram interpretation and management.Copyright: © Singapore Medical Association.

2018 Singapore medical journal

20. A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration Full Text available with Trip Pro

A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration To report a case of atrioventricular block (AVB) which might be associated with the right coronary artery lesion and the novel oral antithrombotic drug ticagrelor mediated by the increasing adenosine plasma concentration (APC).A 65-year-old man was given loading dose of ticagrelor (180 mg) before coronary angiography (...) shifting to clopidogrel, the ECG showed normal sinus rhythm and PR interval depressed to 190 ms and APC dropped from 1.62 umol/L to 0.92 umol/L. The bradycardia and AVB did not occur in the three-month follow-up.It was important to take the ticagrelor induced bradycardia into account particularly with the myocardial infarction of right coronary artery, treated with atrioventricular block drugs after initiating ticagrelor. Also, we should shift ticagrelor to clopidogrel if AVB occurred.

2018 Case reports in vascular medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>